| January 2021 There has been emerging interest in the use of complementary therapies such as hypnotherapy, yoga, or mindfulness meditation to aid in smoking cessation. To date, several of these interventions have shown some promise in preliminary, non-randomized studies, but there is not enough evidence to establish if mind and body practices are as efficacious as other evidence-based smoking cessation treatments. The natural product cytisine, primarily used in Central and Eastern European countries for smoking cessation, is not currently approved by the U.S. Food and Drug Administration (FDA) but has been shown to be effective in helping smokers quit. Complementary therapies can be part of a comprehensive tobacco cessation treatment plan that includes behavioral modifications, and may include pharmaceuticals to decrease cravings, group therapy, or counseling. This issue of the digest highlights the evidence of several complementary health approaches for smoking cessation. Read more »
Learn what current research has to say about:
Read more »
Read more »
Visit NCCIH's website to read the full issue of this month's Clinical Digest.
NCCIH Clinical Digest is a service of the National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH), U.S. Department of Health and Human Services. NCCIH Clinical Digest, a monthly e-newsletter, offers evidence-based information on complementary and integrative health, including scientific literature searches, summaries of NCCIH-funded research, fact sheets for patients, and more.
NCCIH is 1 of 27 institutes and centers at the NIH. The mission of NCCIH is to define, through rigorous scientific investigation, the usefulness and safety of complementary and alternative medicine interventions and their roles in improving health and health care. For additional information, call NCCIH's Clearinghouse toll free at 1-888-644-6226, or visit the NCCIH website at nccih.nih.gov. | 
No comments:
Post a Comment